REQUEST A DEMO
Total
USD $0.00
Search more companies

Aurovitas, Spol. S R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Aurovitas, Spol. S R.O. Profile Updated: April 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

APOTEX ČR was founded in 1992 and is the oldest branch of the largest Canadian pharmaceutical company. It offers more than 70 generic products authorized in 160 types of packaging and dosage. It focuses mainly on general medicine, cardiology, rheumatology, psychiatry, neurology, urology and oncology. Since 2008, offers a range of premium supplements. It focuses primarily on the enzyme preparations, probiotics and cranberry extracts. The medical devices, especially to cover unique gel and wound healing Hemagel are the newest products in the portfolio.

Headquarters
Karlovarska 77/12
Prague; The City of Prague; Postal Code: 16100

Contact Details: Purchase the Aurovitas, Spol. S R.O. report to view the information.

Website: http://www.apotex.cz

Basic Information
Total Employees:
Purchase the Aurovitas, Spol. S R.O. report to view the information.
Outstanding Shares:
Purchase the Aurovitas, Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Aurovitas, Spol. S R.O. report to view the information.
Financial Auditors:
Purchase the Aurovitas, Spol. S R.O. report to view the information.
Incorporation Date:
March 17, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
PACE 2015, o.p.s.
Company Performance
Financial values in the chart are available after Aurovitas, Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-7.11%
Total operating revenue
21.62%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
22.28%
Total equity
11.68%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.47%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?